http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6673540-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14effe3850d2129f863b969dac4f1db8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6897 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-72 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-72 |
| filingDate | 2000-11-17^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-01-06^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0b310e219eef1197fee8a02dd68bf04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0563e9f74a3d41e6723f48f0619aa142 |
| publicationDate | 2004-01-06^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6673540-B1 |
| titleOfInvention | Cell systems having specific interaction of peptide binding pairs |
| abstract | This invention relates to modified host cells which express heterologous fused proteins and methods of screening for test samples having peptide binding activity; wherein the modified host cell comprises: (a) a gene sequence encoding a heterologous fusion protein; the fusion protein comprising a first peptide of a peptide binding pair, or segment of the first peptide, which is joined to either a DNA binding domain or its corresponding transcriptional activation domain of a transcriptional activation protein; (b) a gene sequence encoding a heterologous fusion protein, the fusion protein comprising a second peptide of the peptide binding pair in (a), or a segment thereof, fused to either a DNA binding domain or its corresponding transcriptional activation domain, whichever one is not employed in (a); (c) a reporter gene operatively associated with the transcriptional activation protein, or a portion thereof; (d) optionally, a deletion or mutation in the chromosomal DNA of the host cell for the transcriptional activation protein if present in the selected host cell. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7601533-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7033768-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003124538-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019099678-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006223089-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020347462-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2584211-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2584211-B |
| priorityDate | 1994-06-14^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 663 of 663.